Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold

作者: Maria Elena Manni , Gaetano De Siena , Alessandro Saba , Maja Marchini , Elisa Landucci

DOI: 10.1111/J.1476-5381.2012.02137.X

关键词: Internal medicineLickingMetaboliteEndogenyPsychology3-IodothyronamineThreshold of painEndocrine systemClorgylineHormoneEndocrinology

摘要: Background and Purpose 3-Iodothyronamine (T1AM), an endogenous derivative of thyroid hormones, is regarded as a rapid modulator behaviour metabolism. To determine whether brain hormone levels contribute to these effects, we investigated the effect central administration T1AM on learning pain threshold mice either untreated or pretreated with clorgyline (2.5 mg·kg−1, i.p.), inhibitor amine oxidative metabolism. Experimental Approach T1AM (0.13, 0.4, 1.32 4 μg·kg−1) vehicle was injected i.c.v. into male mice, after 30 min their effects memory acquisition capacity, curiosity were evaluated by following tests: passive avoidance, licking latency hot plate movements hole-board platform. Plasma glycaemia measured using glucorefractometer. Brain triiodothyroxine (T3), thyroxine (T4) HPLC coupled tandem MS. ERK1/2 activation c-fos expression in different regions Western blot analysis. Results T1AM improved decreased stimuli, enhanced raised plasma dose-dependent way, without modifying T3 T4 concentrations. abolished significantly affected clorgyline, suggesting role for some metabolite(s), that interacts at desensitizing target(s). activated ERK areas lower doses than those effective behaviour. Conclusions And Implications T1AM novel enhancer. This feature might have important implications treatment endocrine neurodegenerative-induced disorders.

参考文章(37)
Carol Kilkenny, William Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman, None, Animal research: reporting in vivo experiments: the ARRIVE guidelines British Journal of Pharmacology. ,vol. 160, pp. 1577- 1579 ,(2010) , 10.1111/J.1476-5381.2010.00872.X
Maria Elena Manni, Gaetano De Siena, Alessandro Saba, Maja Marchini, Ilaria Dicembrini, Elisabetta Bigagli, Lorenzo Cinci, Maura Lodovici, Grazia Chiellini, Riccardo Zucchi, Laura Raimondi, 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice British Journal of Pharmacology. ,vol. 166, pp. 650- 658 ,(2012) , 10.1111/J.1476-5381.2011.01823.X
R Zucchi, G Chiellini, T S Scanlan, D K Grandy, Trace amine-associated receptors and their ligands. British Journal of Pharmacology. ,vol. 149, pp. 967- 978 ,(2006) , 10.1038/SJ.BJP.0706948
JC McGrath, GB Drummond, EM McLachlan, C Kilkenny, CL Wainwright, Guidelines for reporting experiments involving animals: the ARRIVE guidelines British Journal of Pharmacology. ,vol. 160, pp. 1573- 1576 ,(2010) , 10.1111/J.1476-5381.2010.00873.X
J. David Sweatt, Erik D. Roberson, A biochemical blueprint for long-term memory. Learning & Memory. ,vol. 6, pp. 381- 388 ,(1999) , 10.1101/LM.6.4.381
M. Rivas, J. R. Naranjo, Thyroid hormones, learning and memory. Genes, Brain and Behavior. ,vol. 6, pp. 40- 44 ,(2007) , 10.1111/J.1601-183X.2007.00321.X
Kristian P. Doyle, Katherine L. Suchland, Thomas M.P. Ciesielski, Nikola S. Lessov, David K. Grandy, Thomas S. Scanlan, Mary P. Stenzel-Poore, Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury Stroke. ,vol. 38, pp. 2569- 2576 ,(2007) , 10.1161/STROKEAHA.106.480277
Thomas S. Scanlan, 3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team? Endocrinology. ,vol. 150, pp. 1108- 1111 ,(2009) , 10.1210/EN.2008-1596
Warren J. L. Wood, Travis Geraci, Aaron Nilsen, Andrea E. DeBarber, Thomas S. Scanlan, Iodothyronamines are Oxidatively Deaminated to Iodothyroacetic Acids in vivo ChemBioChem. ,vol. 10, pp. 361- 365 ,(2009) , 10.1002/CBIC.200800607
W. S. Dhillo, G. A. Bewick, N. E. White, J. V. Gardiner, E. L. Thompson, A. Bataveljic, K. G. Murphy, D. Roy, N. A. Patel, J. N. Scutt, A. Armstrong, M. A. Ghatei, S. R. Bloom, The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents Diabetes, Obesity and Metabolism. ,vol. 11, pp. 251- 260 ,(2009) , 10.1111/J.1463-1326.2008.00935.X